Background: Electroconvulsive therapy (ECT) is indicated for critical psychiatric conditions, which themselves constitute a risk for deep venous thrombosis (DVT) owing to prolonged immobility, dehydration, and venous stasis.
Objective: We describe challenging instances of ECT implementation while taking direct oral anticoagulants (DOACs).
Method: We report on 8 patients receiving DOACs for DVT who were successfully treated with ECT at the University of Yamanashi Hospital. We also provide a literature review on this topic.
Results: There were 6 female patients (the average age was 60.9+/-13.4 y.o.) and diagnoses included major depression, bipolar depression and schizophrenia. DOACs were edoxaban for 4 patients, rivaroxaban for 2, and apixaban for 2. A total of 92 ECT sessions were cautiously and safely completed in collaboration with multidisciplinary medical professionals without problematic adverse events, such as bleeding. A literature search found one case series of warfarin but currently available evidence is confined to sporadic case reports regarding ECT and DOACs for DVT. These reports were represented by successful implementation of ECT to patients receiving treatment with anticoagulants for DVT or thromboembolism. Ours is the first of a successful treatment with ECT while taking apixaban or edoxaban.
Conclusion: A clinical dilemma is that ECT is indicated for critical conditions that are likely to predispose patients to developing DVT. Paucity of data clearly highlights the need for more studies to support a contention that ECT, when carefully performed in consultation with other medical experts, is a viable treatment for those with DVT receiving oral anticoagulants.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.psym.2018.10.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Approaches for difficult-to-induce-seizures electroconvulsive therapy cases (DEC): a Japanese expert consensus.
Ann Gen Psychiatry
January 2025
Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan.
Background: Seizure threshold increases with age and the frequency of electroconvulsive therapy (ECT). Therefore, therapeutic seizures can be difficult to induce, even at maximum stimulus charge with available ECT devices. Such cases are known as difficult-to-induce-seizures electroconvulsive therapy cases (DECs).
View Article and Find Full Text PDFHow does the measurement of anesthetic depth using the patient state index influence the course of electroconvulsive therapy in patients with major depressive disorder?
J Psychiatr Res
January 2025
Department of Medicine, Universitat Internacional de Catalunya, Barcelona. c/ Dr. Josep Trueta s/n, Sant Cugat del Vallès, 08195, Barcelona, Spain. Electronic address:
Background: Determining anesthetic depth has been used to assess the optimal timing of electrical stimulus application in electroconvulsive therapy (ECT). This has improved the quality and effectiveness of seizures, as some anesthetics used can decrease efficacy. This study evaluated the influence of the Patient State Index (PSi) on the course of ECT in patients with major depressive disorder (MDD).
View Article and Find Full Text PDF3,4-dimethylpyrazole phosphate (DMPP) may negate the expected stimulation of elevated atmospheric CO and warming in fertilizer-N loss.
Plant Sci
January 2025
Xuzhou Institute of Agricultural Sciences in Jiangsu Xuhuai District, Xuzhou 221131, China. Electronic address:
People have accepted the clear fact that elevated CO (eCO) and climate warming are happening, but sustainable agricultural systems are still struggling to adapt. 3,4-dimethyl-1H-pyrazol phosphate (DMPP) is currently recognized as a highly effective strategy for reducing nitrogen (N) loss and related environmental impacts. There is still uncertainty, however, whether DMPP could contribute to building climate-resilient ecosystems in a future climate scenario with co-elevated CO and temperature.
View Article and Find Full Text PDFHigh-selenium exposure is associated with modulation of serum lipid metabolism.
Ecotoxicol Environ Saf
January 2025
Hubei Selenium and Human Health Institute, the Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, China; Hubei Provincial Key Lab of Selenium Resources and Bioapplications, Enshi 445000, China. Electronic address:
At present, there is no consensus on the relationship between selenium (Se) exposure and human serum lipid metabolism. The etiological role of high-Se exposure in lipid markers, dyslipidemia, and nonalcoholic fatty liver (NAFLD) remains unclear. We used serum untargeted metabolomics analysis to evaluate whether high-Se exposure is cross-sectionally associated with lipid metabolism in adults from high-Se exposure area (n = 112) and control area (n = 101) in Hubei Province, China.
View Article and Find Full Text PDFA Case of Asymmetric Seizure Termination During an Acute Course of Right Unilateral Electroconvulsive Therapy.
J ECT
January 2025
From the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH.
Electroencephalogram (EEG) monitoring during electroconvulsive therapy (ECT) is commonly done using a 2-channel EEG in order to capture activity from both brain hemispheres, though many institutions may instead opt to utilize a 1-channel EEG, often for reasons of convenience. We present a novel case of asymmetric termination of EEG seizure activity during an acute course of right unilateral ECT, prompting a full neurological workup to investigate potential underlying structural or physiological causative factors. This case assists in informing the necessity of bilateral hemispheric EEG monitoring as well as highlights the importance of searching for undiagnosed or latent neurological dysfunction in certain clinical situations arising during ECT.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!